Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

MBX Biosciences (MBX) Leases (2023 - 2026)

MBX Biosciences has reported Leases over the past 4 years, most recently at $453000.0 for Q1 2026.

  • Quarterly results put Leases at $453000.0 for Q1 2026, up 397.8% from a year ago — trailing twelve months through Mar 2026 was $453000.0 (up 397.8% YoY), and the annual figure for FY2025 was $487000.0, up 309.24%.
  • Leases reached $453000.0 in Q1 2026 per MBX's latest filing, down from $487000.0 in the prior quarter.
  • Across five years, Leases topped out at $551000.0 in Q2 2025 and bottomed at $91000.0 in Q1 2025.
  • Median Leases over the past 4 years was $339500.0 (2023), compared with a mean of $324250.0.
  • The largest annual shift saw Leases tumbled 47.35% in 2024 before it skyrocketed 397.8% in 2026.
  • Over 4 years, Leases stood at $226000.0 in 2023, then plummeted by 47.35% to $119000.0 in 2024, then surged by 309.24% to $487000.0 in 2025, then dropped by 6.98% to $453000.0 in 2026.
  • Business Quant data shows Leases for MBX at $453000.0 in Q1 2026, $487000.0 in Q4 2025, and $520000.0 in Q3 2025.